ELCC 2026: Managing Pulmonary Neuroendocrine Tumors

At ELCC 2026, Alissa Cooper, MD, thoracic medical oncologist at Dana-Farber Cancer Institute, discusses the challenges in diagnosing and managing pulmonary neuroendocrine tumors. She highlights typical and atypical carcinoids and large cell neuroendocrine carcinoma, stressing the importance of expert pathology for accurate classification. Management varies by subtype and stage, with surgery for early disease and systemic therapies guided by receptor status and molecular profiling.